World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
71
Citations
21532
World Ranking
2294
National Ranking
1112

Overview

Jacques Galipeau is affiliated with the University of Wisconsin-Madison in the United States. Their research primarily focuses on the field of Medicine, with substantial contributions to several subfields, including Genetics, Oncology, Surgery, Immunology, and Physiology.

The scientist's main topics of study revolve around mesenchymal stem cell research, with additional attention to cancer cells and metastasis, salivary gland disorders and functions, tissue engineering and regenerative medicine, pancreatic function and diabetes, biomedical ethics and regulation, and head and neck cancer studies.

Jacques Galipeau has published extensively, with frequent appearances in journals such as Cytotherapy, Cancer Research, Biology of Blood and Marrow Transplantation, Frontiers in Immunology, and Science Advances. Cytotherapy stands out as the venue with the highest number of publications by this researcher.

Among their recent papers are:

  • CCL2 and CXCL12 Derived from Mesenchymal Stromal Cells Cooperatively Polarize IL-10+ Tissue Macrophages to Mitigate Gut Injury, 2020, Cell Reports
  • Macrophages at the Nexus of Mesenchymal Stromal Cell Potency: The Emerging Role of Chemokine Cooperativity, 2021, Stem Cells
  • Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match, 2020, Blood Advances
  • Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition, 2021, Cytotherapy
  • Improving mesenchymal stem/stromal cell potency and survival, 2020, Cytotherapy

Jacques Galipeau collaborates frequently with other researchers. Notable coauthors include Iván Martín, Rachele Ciccocioppo, Miguel Forte, Bruce L. Levine, and Bernd Giebel.

Best Publications

  • Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities

    Jacques Galipeau;Luc Sensébé

  • Marrow stromal cells for cellular cardiomyoplasty: Feasibility and potential clinical advantages

    Jih Shiuan Wang;Dominique Shum-Tim;Jacques Galipeau;Edgar G. Chedrawy

  • Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation.

    Moïra François;Raphaëlle Romieu-Mourez;Raphaëlle Romieu-Mourez;Mengyang Li;Jacques Galipeau;Jacques Galipeau

  • Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature.

    S. Viswanathan;Y. Shi;Y. Shi;J. Galipeau;M. Krampera

  • Allogeneic marrow stromal cells are immune rejected by MHC class I– and class II–mismatched recipient mice

    Nicoletta Eliopoulos;John Stagg;Laurence Lejeune;Sandra Pommey

  • The mesenchymal stromal cells dilemma—does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?

    Jacques Galipeau

  • International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

    Jacques Galipeau;Mauro Krampera;John Barrett;Francesco Dazzi

  • Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal.

    Mauro Krampera;Jacques Galipeau;Yufang Shi;Karin Tarte

  • Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats.

    Timothy van Haaften;Roisin Byrne;Sebastien Bonnet;Gael Y. Rochefort

  • Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner

    Moutih Rafei;Philippe M. Campeau;Adriana Aguilar-Mahecha;Marguerite Buchanan

  • Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing

    Moïra François;Moïra François;Ian Bruce Copland;Shala Yuan;Raphaëlle Romieu-Mourez

  • Interferon-γ-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell

    John Stagg;Sandra Pommey;Sandra Pommey;Nicoletta Eliopoulos;Nicoletta Eliopoulos;Jacques Galipeau;Jacques Galipeau

  • Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation.

    Borhane Annabi;Ying‐Ta Lee;Sandra Turcotte;Emmanuelle Naud

  • Cytokine Modulation of TLR Expression and Activation in Mesenchymal Stromal Cells Leads to a Proinflammatory Phenotype

    Raphaëlle Romieu-Mourez;Moïra François;Marie-Noëlle Boivin;Manaf Bouchentouf

  • Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model.

    Abdulaziz Al-Khaldi;Hilal Al-Sabti;Jacques Galipeau;Kevin Lachapelle

  • Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo

    A Al-Khaldi;N Eliopoulos;D Martineau;L Lejeune

  • IDO-Independent Suppression of T Cell Effector Function by IFN-γ–Licensed Human Mesenchymal Stromal Cells

    Raghavan Chinnadurai;Ian B. Copland;Seema R. Patel;Jacques Galipeau

  • Regulation of MHC Class II Expression and Antigen Processing in Murine and Human Mesenchymal Stromal Cells by IFN-γ, TGF-β, and Cell Density

    Raphaëlle Romieu-Mourez;Moïra François;Marie-Noëlle Boivin;John Stagg

  • Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction.

    Moutih Rafei;Jeremy Hsieh;Simon Fortier;MengYang Li

  • Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication.

    Hong Qin;Qing Shao;Heather Curtis;Jacques Galipeau

Frequent Co-Authors

Greg Gibson
Greg Gibson Georgia Institute of Technology
Yufang Shi
Yufang Shi Soochow University
Donald G. Phinney
Donald G. Phinney Scripps Research Institute
Ivan Martin
Ivan Martin University Hospital of Basel
Brian P. Sorrentino
Brian P. Sorrentino St. Jude Children's Research Hospital
Luc Sensebé
Luc Sensebé StromaLab
Moulay A. Alaoui-Jamali
Moulay A. Alaoui-Jamali McGill University
David Lillicrap
David Lillicrap Queen's University
Subra Kugathasan
Subra Kugathasan Emory University
Ernesto L. Schiffrin
Ernesto L. Schiffrin McGill University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring allied healthcare fields can open diverse career opportunities. Many students begin with foundational programs such as easy lpn programs to get into, which offer a quick entry point into nursing and patient care. These programs can provide valuable clinical experience relevant to immunological healthcare settings.

For individuals without a nursing background, online rn programs for non nurses allow a smooth transition into registered nursing. Such pathways are ideal for science graduates who want to integrate immunology knowledge with hands-on nursing practice.

Accelerated options like absn programs with high acceptance rates enable faster degree completion for those holding non-nursing bachelor's degrees. This helps students quickly move into clinical roles supporting immunology research or patient care.

For advanced practice, pursuing accelerated fnp degrees combines specialized nursing skills with knowledge of immunology, preparing graduates for leadership roles in healthcare settings focused on immune-related conditions.

Best Scientists Citing Jacques Galipeau

Trending Scientists